Arterial tortuosity syndrome
ar-TEE-ree-al tor-CHOO-ih-tee sin-drohm
Also known as: ATS
At a Glance
What is Arterial tortuosity syndrome?
Arterial tortuosity syndrome is a rare genetic disorder that affects the connective tissues in the body, leading to twisted and elongated arteries. The cardiovascular system is primarily affected, but it can also impact other systems such as the respiratory and musculoskeletal systems. It is caused by mutations in the SLC2A10 gene, which affects the structural integrity of blood vessels. Over time, the condition can lead to complications such as aneurysms, stenosis, and increased risk of vascular rupture. Early symptoms may include respiratory problems and joint hypermobility, while later symptoms can involve severe cardiovascular issues. Early diagnosis is crucial to manage and monitor potential life-threatening complications. The condition can significantly impact family life, requiring ongoing medical care and lifestyle adjustments. Prognosis varies depending on the severity of vascular involvement and timely intervention. Daily life for affected individuals often involves regular medical check-ups, potential surgical interventions, and lifestyle modifications to reduce cardiovascular risks. Support from healthcare professionals and genetic counseling can help families manage the condition. Despite the challenges, many individuals with ATS can lead fulfilling lives with appropriate medical care. Awareness and understanding of the condition are essential for improving outcomes and quality of life.
Medical Definition
Arterial tortuosity syndrome is a connective tissue disorder characterized by elongated and tortuous arteries due to mutations in the SLC2A10 gene. Pathologically, it involves abnormal collagen and elastin fiber organization within the arterial walls, leading to structural weakness. Histological findings often reveal disorganized elastic fibers and increased ground substance in the vessel walls. It is classified under rare genetic disorders with an autosomal recessive inheritance pattern. Epidemiologically, it is extremely rare, with an estimated prevalence of 1 in 200,000. The disease course can vary, but it often involves progressive vascular complications that require careful monitoring and management.
Arterial tortuosity syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Arterial tortuosity manifests as the twisting and elongation of arteries, which can be detected through imaging studies. This condition is caused by mutations affecting connective tissue integrity, leading to abnormal arterial structure. Over time, the tortuosity can increase, potentially leading to complications such as aneurysms. In daily life, patients may experience reduced blood flow and increased risk of vascular events, necessitating regular monitoring and possible surgical intervention.
Aneurysms present as localized dilations in the arterial walls, which can be life-threatening if they rupture. They occur due to the weakened arterial walls resulting from connective tissue defects. As the condition progresses, aneurysms may enlarge, increasing the risk of rupture. Patients need to manage this risk through regular imaging and, in some cases, surgical repair to prevent catastrophic outcomes.
Hypertension in arterial tortuosity syndrome is characterized by elevated blood pressure due to altered vascular resistance. The tortuous arteries create increased resistance to blood flow, leading to higher pressure. Without management, hypertension can lead to further vascular complications and organ damage. Patients are often prescribed antihypertensive medications and advised on lifestyle changes to control blood pressure.
Common
Joint hypermobility is observed as an increased range of motion in the joints, often leading to joint pain and instability. This is due to the same connective tissue defects affecting the arteries, impacting joint structure and function. Over time, excessive joint movement can lead to early-onset arthritis and chronic pain. Patients may benefit from physical therapy and supportive devices to stabilize joints and reduce discomfort.
Skin hyperextensibility is noted by the ability to stretch the skin more than usual, which can be visually apparent. This occurs because of abnormalities in collagen and other connective tissue components. As patients age, the skin may become more prone to bruising and injury. Protective measures and skin care routines are recommended to minimize skin damage and maintain integrity.
Facial dysmorphism includes distinct facial features such as a long face, downslanting palpebral fissures, and a high-arched palate. These features arise from the underlying connective tissue disorder affecting craniofacial development. The dysmorphic features are typically present from birth and remain stable throughout life. While they do not usually impact health, they can affect self-esteem, and counseling may be beneficial.
Less Common
Pulmonary artery stenosis is characterized by the narrowing of the pulmonary arteries, which can lead to respiratory difficulties. This narrowing results from abnormal arterial development and connective tissue defects. Over time, it can cause increased pressure in the right side of the heart and reduced oxygenation. Management may include surgical intervention or catheter-based procedures to relieve the stenosis.
Gastrointestinal issues may include symptoms such as abdominal pain, diarrhea, or constipation, linked to vascular abnormalities in the gastrointestinal tract. These symptoms result from compromised blood flow and connective tissue integrity in the gut. They may fluctuate over time, with periods of exacerbation. Dietary modifications and medications can help manage these symptoms and improve quality of life.
What Causes Arterial tortuosity syndrome?
Arterial tortuosity syndrome is primarily caused by mutations in the SLC2A10 gene, located on chromosome 20q13. The SLC2A10 gene encodes the GLUT10 protein, which is involved in glucose transport across cell membranes. Mutations in SLC2A10 lead to structural changes in GLUT10, impairing its ability to transport glucose effectively. This disruption in glucose transport affects cellular energy balance and can lead to altered cellular metabolism. Dysfunction in the endoplasmic reticulum and mitochondrial pathways results from this metabolic imbalance, causing stress and potential apoptosis in vascular cells. Neighboring cells and tissues experience increased oxidative stress and inflammation due to the release of reactive oxygen species. Neuroinflammation may be exacerbated by immune cell activation, contributing to vascular and neural damage. Degeneration of connective tissues, including white matter, occurs as a result of chronic inflammation and structural protein degradation. Symptoms manifest in a pattern reflecting the most affected tissues, such as the cardiovascular system, due to the high metabolic demand and sensitivity to glucose transport disruptions. The variability in disease severity among patients can be attributed to differences in mutation types, genetic background, and environmental factors. Some patients may have compensatory mechanisms that mitigate the effects of GLUT10 dysfunction, leading to milder symptoms. Others may experience more severe manifestations due to additional genetic or epigenetic factors that exacerbate the condition. The immune response may further contribute to tissue damage, influencing the progression and severity of symptoms. Understanding the precise molecular pathways affected by SLC2A10 mutations can aid in developing targeted therapies. Research into the role of GLUT10 in other tissues may reveal additional insights into the systemic effects of arterial tortuosity syndrome.
How is Arterial tortuosity syndrome Diagnosed?
Typical age of diagnosis: Arterial tortuosity syndrome is often diagnosed in early childhood, typically when characteristic symptoms such as elongated and tortuous arteries become apparent. Diagnosis can occur earlier if there is a known family history, prompting genetic testing in infancy. In some cases, diagnosis may be delayed until adolescence or adulthood if symptoms are mild or atypical. Early diagnosis is crucial for managing potential complications and guiding family planning.
The clinician looks for signs of connective tissue disorders, such as hyperextensible skin, joint hypermobility, and characteristic facial features. A detailed family history is crucial, especially noting any relatives with similar symptoms or early cardiovascular events. Physical examination may reveal skin laxity, joint hypermobility, and distinctive facial features like a long face or down-slanting palpebral fissures. This step helps to differentiate arterial tortuosity syndrome from other connective tissue disorders and guides further diagnostic testing.
Magnetic Resonance Angiography (MRA) or Computed Tomography Angiography (CTA) is typically used to visualize the vascular system. These imaging modalities reveal elongated, tortuous arteries, particularly in the aorta and medium-sized arteries. The presence of these abnormalities strongly supports the diagnosis of arterial tortuosity syndrome. Imaging also helps exclude other conditions like Loeys-Dietz syndrome or Marfan syndrome, which may present with similar vascular findings.
Routine blood tests are generally not diagnostic but can help assess overall health and organ function. Specific biomarkers are not typically sought in arterial tortuosity syndrome, as it is primarily a structural disorder. Abnormal results in connective tissue markers might prompt further investigation into related syndromes. Laboratory tests guide the clinician in monitoring the patient's health and planning further genetic testing.
Genetic testing focuses on sequencing the SLC2A10 gene, where mutations are known to cause arterial tortuosity syndrome. Mutations typically involve missense or nonsense changes that affect the gene's function. Identifying a pathogenic mutation in SLC2A10 confirms the diagnosis of arterial tortuosity syndrome. Genetic results are crucial for family counseling, as they inform recurrence risks and guide testing in relatives.
Arterial tortuosity syndrome Treatment Options
Antihypertensive drugs, such as beta-blockers, are used to reduce blood pressure and decrease stress on the arterial walls. These drugs work by blocking the effects of adrenaline, leading to a slower heart rate and reduced blood pressure. Commonly used medications include propranolol and atenolol. Clinical evidence suggests that controlling blood pressure can reduce the risk of vascular complications, although it does not reverse arterial tortuosity. Side effects may include fatigue, dizziness, and cold extremities.
Physical therapy focuses on improving joint stability and mobility through targeted exercises. The therapeutic goals include enhancing muscle strength, reducing joint pain, and preventing dislocations. Sessions are typically conducted twice a week and last for about an hour each. Measurable outcomes include improved range of motion and decreased frequency of joint-related issues. Long-term benefits include enhanced quality of life and reduced risk of musculoskeletal complications.
Surgery may be indicated for severe arterial tortuosity causing significant blood flow obstruction or aneurysm risk. The procedure involves resection and reconstruction of affected arterial segments to restore normal blood flow. Expected benefits include reduced risk of vascular rupture and improved organ perfusion. Surgical risks include bleeding, infection, and potential damage to surrounding structures. Post-operative care requires close monitoring and follow-up imaging to assess surgical success.
A multidisciplinary team typically includes cardiologists, geneticists, physical therapists, and psychologists. Specific interventions focus on cardiovascular monitoring, genetic counseling, and physical rehabilitation. Psychosocial support strategies address the emotional and psychological impact of living with a chronic condition. Family education is crucial for understanding the condition and managing daily challenges. Long-term monitoring involves regular follow-ups to assess disease progression and adjust treatment plans as needed.
When to See a Doctor for Arterial tortuosity syndrome
- Severe chest pain — this could indicate aortic dissection, a life-threatening emergency requiring immediate medical intervention.
- Sudden vision loss — this may suggest retinal artery involvement, necessitating urgent evaluation to prevent permanent blindness.
- Severe abdominal pain — could be a sign of mesenteric artery involvement, which can lead to bowel ischemia and requires emergency care.
- Persistent headache — may indicate increased intracranial pressure or vascular involvement, and should be evaluated by a healthcare provider.
- Unexplained fatigue — could suggest cardiovascular compromise, warranting further investigation by a doctor.
- Intermittent claudication — suggests possible peripheral artery involvement, and should be assessed by a vascular specialist.
- Mild dizziness — monitor for changes in frequency or severity and consult a doctor if it worsens.
- Occasional palpitations — keep track of occurrences and consult a healthcare provider if they become more frequent or severe.
Arterial tortuosity syndrome — Frequently Asked Questions
Is this condition hereditary?
Arterial tortuosity syndrome is inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations. Parents of an individual with this condition are carriers, with a 25% chance of passing the condition to their children. De novo mutations are rare but possible. Carrier status does not typically affect health but genetic counseling is recommended for family planning. Genetic counseling can provide information on risks and testing options.
What is the life expectancy for someone with this condition?
Life expectancy can vary widely depending on the severity and management of the condition. Early diagnosis and intervention can improve outcomes significantly. Mortality is often due to cardiovascular complications such as aortic dissection. With proper treatment and monitoring, individuals can have a near-normal life expectancy. Realistic expectations should include regular medical follow-ups and lifestyle adjustments.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves genetic testing, imaging studies, and clinical evaluation by a geneticist and cardiologist. The time from first symptoms to diagnosis can vary, often taking months to years due to the rarity of the condition. Specialists involved usually include geneticists, cardiologists, and radiologists. Delayed diagnosis is often due to the overlap of symptoms with other vascular disorders. Confirmation is achieved through genetic testing identifying specific gene mutations.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy and novel pharmacological approaches to manage arterial tortuosity syndrome. ClinicalTrials.gov is a resource for finding ongoing trials, and discussing options with your doctor is crucial. Questions for your doctor should include potential eligibility for trials and expected outcomes. New treatments are in the early stages, with realistic timelines extending several years. Staying informed through medical updates and patient organizations is recommended.
How does this condition affect daily life and activities?
Arterial tortuosity syndrome can impact mobility and self-care due to cardiovascular and musculoskeletal issues. Educational accommodations may be necessary for children with associated learning difficulties. Social and emotional challenges include coping with a chronic condition and potential isolation. Family burden can be significant, requiring support and adaptation. Supportive measures include physical therapy, counseling, and connecting with patient communities.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Arterial Tortuosity Syndrome.
Adam MP, Bick S, Mirzaa GM et al. · Unknown Journal · 1993 · PMID: 25392904
- 2.Arterial Tortuosity Syndrome: Unraveling a Rare Vascular Disorder.
Ekhator C, Devi M, Barker C et al. · Cureus · 2023 · PMID: 37692180
- 3.Arterial Tortuosity Syndrome.
Van Berkel B, Sneyers V · Radiology · 2024 · PMID: 39254450
- 4.Arterial tortuosity syndrome.
Nanayakkara DNP, Hartley R, Wijesinghe HE et al. · BMJ Case Rep · 2025 · PMID: 40759497
- 5.Arterial tortuosity in pediatric Loeys-Dietz syndrome patients.
Brunet-Garcia L, Prabaharan P, Bruyndonckx L et al. · Am J Med Genet A · 2024 · PMID: 37916856
- 6.[Arterial tortuosity syndrome].
Meyer S, Faiyaz-Ul-Haque M, Zankl M et al. · Klin Padiatr · 2005 · PMID: 15640971
- 7.Arterial Tortuosity.
Ciurică S, Lopez-Sublet M, Loeys BL et al. · Hypertension · 2019 · PMID: 30852920
- 8.Arterial Tortuosity Syndrome: An Approach through Imaging Perspective.
Bhat V · J Clin Imaging Sci · 2014 · PMID: 25250193
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-18